Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 07 2023
Historique:
medline: 25 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Practice guidelines often provide recommendations in which the strength of the recommendation is dissociated from the quality of the evidence. To create a clinical guideline for the diagnosis and management of adult bacterial infective endocarditis (IE) that addresses the gap between the evidence and recommendation strength. This consensus statement and systematic review applied an approach previously established by the WikiGuidelines Group to construct collaborative clinical guidelines. In April 2022 a call to new and existing members was released electronically (social media and email) for the next WikiGuidelines topic, and subsequently, topics and questions related to the diagnosis and management of adult bacterial IE were crowdsourced and prioritized by vote. For each topic, PubMed literature searches were conducted including all years and languages. Evidence was reported according to the WikiGuidelines charter: clear recommendations were established only when reproducible, prospective, controlled studies provided hypothesis-confirming evidence. In the absence of such data, clinical reviews were crafted discussing the risks and benefits of different approaches. A total of 51 members from 10 countries reviewed 587 articles and submitted information relevant to 4 sections: establishing the diagnosis of IE (9 questions); multidisciplinary IE teams (1 question); prophylaxis (2 questions); and treatment (5 questions). Of 17 unique questions, a clear recommendation could only be provided for 1 question: 3 randomized clinical trials have established that oral transitional therapy is at least as effective as intravenous (IV)-only therapy for the treatment of IE. Clinical reviews were generated for the remaining questions. In this consensus statement that applied the WikiGuideline method for clinical guideline development, oral transitional therapy was at least as effective as IV-only therapy for the treatment of IE. Several randomized clinical trials are underway to inform other areas of practice, and further research is needed.

Identifiants

pubmed: 37523190
pii: 2807791
doi: 10.1001/jamanetworkopen.2023.26366
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2326366

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Auteurs

Emily G McDonald (EG)

Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.

Gloria Aggrey (G)

Montgomery Medical Associates, Rockville, Maryland.

Abdullah Tarik Aslan (A)

The University of Queensland, Faculty of Medicine, Centre for Clinical Research, Brisbane, Queensland, Australia.

Michael Casias (M)

Jersey Shore University Medical Center, Neptune, New Jersey.

Nicolas Cortes-Penfield (N)

Division of Infectious Diseases, University of Nebraska Medical Center, Omaha.

Mei Qin Denise Dong (MQD)

New York Health and Hospitals-Bellevue Hospital, New York.

Susan Egbert (S)

Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada.

Brent Footer (B)

Providence Portland Medical Center, Portland, Oregon.

Burcu Isler (B)

University of Queensland, Centre for Clinical Research, Brisbane, Queensland, Australia.

Madeline King (M)

Cooper University Healthcare, Camden, New Jersey.

Mira Maximos (M)

Women's College Hospital, Toronto, Ontario, Canada.

Terence C Wuerz (TC)

Departments of Internal Medicine & Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Ahmed Abdul Azim (AA)

Division of Infectious Diseases, Allergy and Immunology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

Jhongert Alza-Arcila (J)

Infectious Diseases Fellowship, Universidad de Antioquia, Medellín, Colombia.

Anthony D Bai (AD)

Division of Infectious Diseases, Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Michelle Blyth (M)

Louisiana State University, Baton Rouge.

Tom Boyles (T)

Right to Care, NPC, Centurion, South Africa and London School of Hygiene and Tropical Medicine, London, United Kingdom.

Juan Caceres (J)

Division of Internal Medicine, Michigan Medicine, Ann Arbor.

Devin Clark (D)

Los Angeles County and University of Southern California Medical Center, Los Angeles.

Kusha Davar (K)

Los Angeles County and University of Southern California Medical Center, Los Angeles.

Justin T Denholm (JT)

Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Graeme Forrest (G)

Rush University Medical Center, Chicago, Illinois.

Bassam Ghanem (B)

King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Stefan Hagel (S)

Institute for Infectious Diseases and Infection Control, Jena University Hospital-Friedrich Schiller University Jena, Jena, Germany.

Alexandra Hanretty (A)

Cooper University Healthcare, Camden, New Jersey.

Fergus Hamilton (F)

Infection Science, North Bristol NHS Trust, Bristol, United Kingdom.

Philipp Jent (P)

Department of Infectious Diseases, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.

Minji Kang (M)

Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern, Dallas.

Geena Kludjian (G)

Cooper University Healthcare, Camden, New Jersey.

Tim Lahey (T)

University of Vermont Medical Center, Burlington.

Jonathan Lapin (J)

University of Maryland Medical Center, Baltimore.

Rachael Lee (R)

University of Alabama at Birmingham.

Timothy Li (T)

Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong.

Dhara Mehta (D)

Bellevue Hospital Center, New York, New York.

Jessica Moore (J)

MemorialCare, Fountain Valley, California.

Clayton Mowrer (C)

University of Nebraska Medical Center, Children's Hospital and Medical Center, Omaha.

Georges Ouellet (G)

Hôpital Maisonneuve Rosemont, Montréal, Quebec, Canada.

Rebecca Reece (R)

Section of Infectious Diseases, West Virginia University, Morgantown.

Jonathan H Ryder (JH)

Division of Infectious Diseases, University of Nebraska Medical Center, Omaha.

Alexandre Sanctuaire (A)

Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec, Canada.

James M Sanders (JM)

University of Texas Southwestern Medical Center, Dallas.

Bobbi Jo Stoner (BJ)

University of Kentucky Medical Center, Lexington.

Jessica M So (JM)

Los Angeles County and University of Southern California Medical Center, Los Angeles.

Jean-François Tessier (JF)

Division of Nephrology, Maisonneuve-Rosemont Hospital, Montréal, Quebec, Canada.

Raghavendra Tirupathi (R)

Keystone Infectious Diseases, Chambersburg, Pennsylvania.

Steven Y C Tong (SYC)

Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Noah Wald-Dickler (N)

Los Angeles County and University of Southern California Medical Center, Los Angeles.

Arsheena Yassin (A)

Robert Wood Johnson University Hospital, New Brunswick, New Jersey.

Christina Yen (C)

Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern, Dallas.

Brad Spellberg (B)

Los Angeles County and University of Southern California Medical Center, Los Angeles.

Todd C Lee (TC)

Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH